相似文献
1
Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants.
China CDC Wkly. 2021 Nov 12;3(46):977-982. doi: 10.46234/ccdcw2021.216.
2
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
Emerg Microbes Infect. 2021 Dec;10(1):1751-1759. doi: 10.1080/22221751.2021.1969291.
3
Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.
medRxiv. 2021 Feb 5:2021.02.02.21250799. doi: 10.1101/2021.02.02.21250799.
4
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
引用本文的文献
1
The Ongoing Epidemics of Seasonal Influenza A(H3N2) in Hangzhou, China, and Its Viral Genetic Diversity.
Viruses. 2025 Apr 4;17(4):526. doi: 10.3390/v17040526.
2
What determines gait speed in community-living older adults? A relative weight analysis.
Eur Geriatr Med. 2025 Apr 17. doi: 10.1007/s41999-025-01208-w.
3
Whole-genome analysis of circulating influenza A virus (H3N2) strains in Shanghai, China from 2005 to 2023.
Emerg Microbes Infect. 2024 Dec;13(1):2396867. doi: 10.1080/22221751.2024.2396867. Epub 2024 Sep 5.
4
Adolescents With Breakthrough COVID-19 Infections Requiring Hospitalization: A Multicenter Retrospective Study.
Cureus. 2024 May 23;16(5):e60940. doi: 10.7759/cureus.60940. eCollection 2024 May.
5
Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies.
Int Rev Neurobiol. 2022;165:173-196. doi: 10.1016/bs.irn.2022.04.005. Epub 2022 Jul 9.
6
A Chess and Card Room-Induced COVID-19 Outbreak and Its Agent-Based Simulation in Yangzhou, China.
Front Public Health. 2022 Jun 17;10:915716. doi: 10.3389/fpubh.2022.915716. eCollection 2022.
7
SARS-CoV-2: phenotype, genotype, and characterization of different variants.
Cell Mol Biol Lett. 2022 Jun 17;27(1):50. doi: 10.1186/s11658-022-00352-6.
本文引用的文献
1
Guangdong's Study of the Effectiveness of China's Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant.
China CDC Wkly. 2021 Aug 20;3(34):728-730. doi: 10.46234/ccdcw2021.179.
2
Field Simulation of Aerosol Transmission of SARS-CoV-2 in a Special Building Layout - Guangdong Province, China, 2021.
China CDC Wkly. 2021 Aug 20;3(34):711-715. doi: 10.46234/ccdcw2021.176.
3
Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1167-1169. doi: 10.15585/mmwr.mm7034e4.
4
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
5
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
J Autoimmun. 2021 Nov;124:102715. doi: 10.1016/j.jaut.2021.102715. Epub 2021 Aug 11.
6
Emerging SARS-CoV-2 variants of concern and potential intervention approaches.
Crit Care. 2021 Jul 12;25(1):244. doi: 10.1186/s13054-021-03662-x.
7
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Cell. 2021 Aug 5;184(16):4220-4236.e13. doi: 10.1016/j.cell.2021.06.020. Epub 2021 Jun 17.
8
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.2100557.
9
Delta coronavirus variant: scientists brace for impact.
Nature. 2021 Jul;595(7865):17-18. doi: 10.1038/d41586-021-01696-3.
10
Genetic Variants of SARS-CoV-2-What Do They Mean?
JAMA. 2021 Feb 9;325(6):529-531. doi: 10.1001/jama.2020.27124.
Zotero 插件